1.Immunogenicity of formaldehyde and binary ethylenimine inactivated infectious bursal disease virus in broiler chicks.
Mudasser HABIB ; Iftikhar HUSSAIN ; Hamid IRSHAD ; Zong-zhao YANG ; Jiang-bing SHUAI ; Ning CHEN
Journal of Zhejiang University. Science. B 2006;7(8):660-664
Infectious bursal disease virus (IBDV) was inactivated by two different chemicals--formaldehyde and binary ethylenimine (BEI). Formaldehyde was used at 0.1% and 0.2%, while BEI was used at concentrations of 0.001 and 0.002 mol/L. These four vaccines were tested for their efficiency in generating humoral immune response in different groups of broiler chicks. Both BEI-inactivated vaccines gave relatively higher antibody titers and were almost twice as efficient as formaldehyde-inactivated ones.
Animals
;
Antibodies, Viral
;
blood
;
Aziridines
;
pharmacology
;
Chickens
;
Formaldehyde
;
pharmacology
;
Infectious bursal disease virus
;
immunology
;
Vaccination
;
Vaccines, Inactivated
;
immunology
;
Viral Vaccines
;
immunology
2.Preparation and identification of monoclonal antibodies against infectious bursal disease virus (IBDV) VP4.
Ya'nan LIU ; Xiaying LI ; Zhonghua LI ; Yongqiang WANG ; Xiaoqi LI ; Hong CAO ; Shijun J ZHENG
Chinese Journal of Biotechnology 2014;30(11):1660-1668
Infectious bursal disease virus (IBDV) VP4 plays an important role in immunosuppression of host. In order to develop monoclonal antibodies (McAbs) against VP4, we vaccinated BALB/c mice with His-VP4, screened and subcloned positive clones. We established 4 hybridoma cell lines that stably secreted McAbs against VP4 and named these cell lines 3B3, 3H11, 4C8 and 4G6, respectively. We tested the dissociation constant (Kd) of these McAbs, and found that their K(d)s were 4.61 x 10(-11), 1.71 x 10(-10), 4.26 x 10(-11), 5.02 x 10(-11), respectively. The isotypes of these McAbs were determined to be IgG1, IgG1, IgG2b and IgG1. These McAbs specifically bound to VP4 in IBDV infected DF-1 cells as demonstrated by Western blotting analysis and fluorescence antibody assay. These McAbs would help to detect IBDV infection and to analyze the biological activities of IBDV VP4.
Animals
;
Antibodies, Monoclonal
;
biosynthesis
;
Blotting, Western
;
Cell Line
;
Fluorescent Antibody Technique
;
Hybridomas
;
Infectious bursal disease virus
;
Mice
;
Mice, Inbred BALB C
;
Viral Structural Proteins
;
immunology
3.Identification of VP3 antigenic epitopes of infectious bursal disease virus.
Xiao-yun DENG ; Yu-long GAO ; Hong-lei GAO ; Xiao-le QI ; Xiao-yan WANG ; Xiao-mei WANG
Chinese Journal of Virology 2007;23(4):305-311
Infectious bursal disease virus(IBD) causes infectious bursal disease (IBD), which infects bursal of chicken and can evoke immune suppression. This study identified the antigenic epitopes of four McAbs to IBDV VP3(HRB-3F, HRB-7B, HRB-7C and HRB-10E)with pepscan. A set of 17 partially overlapping or consecutive peptides (P1-P17) spanning VP3 were expressed for epitope screening by pepscan. Finally, two antigenic epitopes, 109-119aa and 177-190aa of IBDV VP3, were identified by Western blot and ELISA. The peptides on epitopes could react with IBDV, and they had better immunnogenicity. The sequences of epitopes were compared with that of several other IBDV strains in the same region, and was found they were totally homologous. This study showed the two epitopes were novel conserved linear B cell epitopes on the VP3 of IBDV. This study provides basis for the development of immunity-based prophylactic, therapeutic and diagnostic measures for control of IBD and further for structural and functional analysis of IBDV.
Animals
;
Antibodies, Monoclonal
;
immunology
;
Antibodies, Viral
;
blood
;
immunology
;
Blotting, Western
;
Capsid Proteins
;
genetics
;
immunology
;
metabolism
;
Enzyme-Linked Immunosorbent Assay
;
Epitopes
;
genetics
;
immunology
;
metabolism
;
Immune Sera
;
immunology
;
Immunization
;
Immunohistochemistry
;
Infectious bursal disease virus
;
genetics
;
immunology
;
metabolism
;
Mice
;
Mice, Inbred BALB C
4.Establishment and biological properties of hybridoma cell lines secreting anti-IBDV idiotypic antibodies.
Rui-Liang ZHU ; Zhi-Zhong CUI ; Jing ZHAO
Chinese Journal of Biotechnology 2003;19(4):462-466
In recent years, the prevention and cure of infectious bursal disease (IBD) have become more and more difficult due to the emergence of very virulent strains of infectious bursal disease virus (vvIBDV) and the variant strains of IBDV. In this research, the hybridoma cell lines which secretes anti-idiotypic antibodies against anti-IBDV IgG were established. According to the Jerne's theory of immune network, the use of the anti-idiotypic antibodies as a vaccine will be a new method for the prevention of IBD. In this study, the SPF chickens were inoculated with the IBDV- SD strain, and the bursal was obtained from the died chickens. The bursal was then homogenized and frozen-thawed 3 cycles, and the virus samples were prepared by cane sugar density gradient centrifugation and dialysis. Typical IBDV particles were observed under an electron microscope, and the concentration of the virus protein measured by ultraviolet absorbance spectrophotometry was 10.8 mg/mL. SPF chickens were immunized with the virus and the highly immunized sera were prepared and purified by Sulfuric acid ammonia salt out and Sephadex G-25 chromatography. Then, Balb/C mice of six or eight weeks old were immunized interapertoneally(I. P.) with purified antibodies to IBDV at regular intervals. SP2/0 myeloma cells were fused with the spleencytes from the immunized mice at a ratio of 10:1, in 50% polyethylene glycol (1540) and were then cultured in HAT until all the SP2/0 cells died. The hybridoma cells were selected by ELISA and the highly positive holes were cloned 3 times with the method of limited dilution. Two strains (2B6 strain,5F4 strain) of hybridoma cells were obtained, which were shown by ELISA to steadily secrete anti-IBDV idiotypic antibodies. The chromosome number of the two hybridoma cells were about 88 - 106, 95 in average, and the antibodies secreted belonged to the types of IgG1 and Kappa. Balb/c mice of 3 months old were inoculated I.P. with about 10(7) hybridoma cells per capita, and the ascites were collected 12 days later and the titre of anti-IBDV idiotypic antibodies measured by ELISA was 1 :25600 (for 2B6) and 1:12800 (for 5F4) . The ascites containing the anti-IBDV idiotypic antibodies were emulsified with complete or incomplete Freund's adjuvants, and the anti-IBDV idiotypic antibody vaccine was obtained. SPF and common Jingbai chickens were immunized with the vaccine obtained. The immunized chickens with the vaccine were inoculated with IBDV-SD strain at a dose of 2000 ELD50 after twoimmunizations. All the 10 SPF chickens in the non-immunized group were sick, and 8 of them died; and 5 out of the 50 SPF chickens immunized group got sick and 2 died. All the 10 common Jingbai chickens in the control group were sick, and 6 died; 7 of the 30 immunized common Jingbai chickens got sick and only 1 died. Chi2 analysis showed that the difference between the immunized and the non-immunized groups in both the SPF and the common Jingbai chickens were significant (P < 0.01). Our result indicated that the anti-IBDV idiotypic antibody vaccine well protected chickens and had a great potential in both research and clinical application.
Animals
;
Antibodies, Anti-Idiotypic
;
biosynthesis
;
immunology
;
Birnaviridae Infections
;
immunology
;
Cell Line, Tumor
;
Chickens
;
Enzyme-Linked Immunosorbent Assay
;
Hybridomas
;
immunology
;
metabolism
;
Infectious bursal disease virus
;
immunology
;
Male
;
Mice
;
Mice, Inbred BALB C
;
Spleen
;
cytology
;
Viral Vaccines
;
biosynthesis
;
immunology
5.Preparation and primary analysis of monoclonal antibodies against VP5 protein of chicken infectious bursal disease virus.
Ning ZHANG ; Hong-Lei GAO ; Yu-Long GAO ; Jun-Shan LI ; Xiao-Yan WANG ; Duo-Liang RAN ; Xiao-Mei WANG
Chinese Journal of Biotechnology 2007;23(4):719-723
Infectious bursal disease virus (IBDV), the causative agent of a highly contagious disease in chickens, carries a small nonstructural protein (NS). In this study, vvIBDV Gx-VP5 genes were cloned into plasmid pET30a( + ) and expressed in E. coli with IPTG inducing. BALB/c mice were immunized with the purified recombinant fusion protein. SP2/0 myeloma cells and spleen cells of BALB/c mice were fused by PEG(MW1500), three hybridoma cell lines were examined by indirect ELISA and clone for three times by limited dilution, and were named as 4B4, 6D12, 3E8. The subtype of the monoclonal antibodies were IgG1 with a subtype identified ELISA kit, and light chains were kappa. The ascites titers of monoclonal antibodies were 5 x 10(4), 3.5 x 10(4), 3 x 10(4) by indirect ELISA, respectively. Indirect ELISA and Western blot results showed that the monoclonal antibodies only acted with VP5 protein, IF analysis indicated that three monoclonal antibodies acted with IBDV Gt. There were specific fluorescence in detected Vero E6 cells which transient expressed VP5 protein by IFA. Therefore, monoclonal antibodies specific to IBDV VP5 proteins are specific method for detected VP5 proteins, and base on establish stabilize expressed VP5 protein Vero cell lines to research IBDV VP5 protein function.
Animals
;
Antibodies, Monoclonal
;
biosynthesis
;
immunology
;
Antibodies, Viral
;
biosynthesis
;
immunology
;
Chickens
;
Escherichia coli
;
genetics
;
metabolism
;
Female
;
Hybridomas
;
secretion
;
Immunization
;
Infectious bursal disease virus
;
immunology
;
Mice
;
Mice, Inbred BALB C
;
Viral Nonstructural Proteins
;
immunology
6.Co-expression, purification and bioassay of three avian viral antigens.
Suling ZHANG ; Mengyue WANG ; Yanwei WANG ; Peng WU ; Wenqiang PANG ; Kegong TIAN
Chinese Journal of Biotechnology 2020;36(10):2066-2075
To achieve uniform soluble expression of multiple proteins in the same Escherichia coli strain, and simplify the process steps of antigen production in genetic engineering subunit multivalent vaccine, we co-expressed three avian virus proteins including the fowl adenovirus serotype 4 (FAdV-4) Fiber-2 protein, infectious bursal disease virus (IBDV) VP2 protein and egg-drop syndrome virus (EDSV) Fiber protein in E. coli BL21(DE3) cells after optimization of gene codon, promoter, and tandem expression order. The purified proteins were analyzed by Western blotting and agar gel precipitation (AGP). The content of the three proteins were well-proportioned after co-expression and the purity of the purified proteins were more than 80%. Western blotting analysis and AGP experiment results show that all the three co-expression proteins had immunoreactivity and antigenicity. It is the first time to achieve the three different avian virus antigens co-expression and co-purification, which simplified the process of antigen production and laid a foundation for the development of genetic engineering subunit multivalent vaccine.
Animals
;
Antigens, Viral/genetics*
;
Biological Assay
;
Chickens/immunology*
;
Escherichia coli/genetics*
;
Infectious bursal disease virus/immunology*
;
Poultry Diseases
;
Vaccines, Synthetic/isolation & purification*
;
Viral Structural Proteins/immunology*
;
Viral Vaccines/immunology*
7.Immunogenicity of recombinant Lactobacillus casei expressing VP2 protein of infectious bursal disease virus in chickens.
Hongli LIN ; Shenda HOU ; Song WANG ; Yupeng WANG ; Yunyan LUANI ; Xilin HOU
Chinese Journal of Biotechnology 2014;30(11):1679-1690
In order to determine immunogenicity and protective effect in chickens, we used the IBDV (Infectious bursal disease virus)-Vp2/Lactobacillus casei as antigen transfer system. First, the immunized and control chickens were challenged by IBDV/DQ at lethal dose to determine the protective ratio. Second, chickens were orallyand intranasally vaccinated twice with 10(9) CFU/mL pLA-VP2/L. casei, pLA/L. casei and PBS as negativecontrol and commercial vaccine as positive control. The bursa injury and the lesion score wererecorded post challenge. The level of specific IgG and sIgA in pLA-VP2/L. casei and positive control groups was significantly higher than that in negativecontrol groups. The protection efficacy in pLA-VP2/L. casei oral group was higher than that inintranasal group. The SI. of pLA-VP2/L. casei oral group was significant higher than other groups. The lesion score indicated the pLA-VP2/L. casei was safer than commercial vaccine for bursa. Collectively, the pLA-VP2/L. casei could be a vaccine candidate for IBDV.
Animals
;
Antibodies, Viral
;
blood
;
Antibody Formation
;
Birnaviridae Infections
;
prevention & control
;
veterinary
;
Chickens
;
Infectious bursal disease virus
;
Lactobacillus casei
;
Poultry Diseases
;
prevention & control
;
Recombinant Proteins
;
immunology
;
Viral Structural Proteins
;
immunology
;
Viral Vaccines
;
immunology
8.Recombinant Vp2 protein of infectious bursal disease virus AH1 strain expressed in insect cells: a vaccine candidate.
Wei OUYANG ; Yongshan WANG ; Yu ZHOU ; Haibin ZHANG ; Yude TANG
Chinese Journal of Biotechnology 2010;26(5):595-603
Protective immune response of the available IBD vaccine is insufficient to fully protect against the prevailing strain of the infectious bursal disease virus (IBDV). Such a vaccination escape IBDV field isolate idenfied from Anhui province of China in December 2007, where IBD broke out at 2 weeks post vaccination. The IBDV vp2 gene was cloned into pFastBacHTA donor plasmid, followed by generation of the recombinant bacmid DNA pBac-VP2. The latter was used to transfect insect cell Sf9 with Lipofectamine to produce recombinant baculovirus vBac-VP2. The Sf9 cells infected with vBac-VP2 were stained positive against IBDV antibody using the indirect immunofluorescence assay (IFA), which was also confirmed by the detection of IBDV Vp2 protein in the infected Sf9 cells by IBDV sandwich ELISA. Western blotting revealed that the calculated protein of approximately 53 kDa was in the expressed in the insect cells. Moreover, virus-like particles (VLPs) and "inclusion body-like"structure in the infected Sf9 cells were observed under electron microscopy. We further developed an indirect ELISA for the detection of the IBDV antibodies, which was specific and sensitive. In addition, the lysates of vBac-VP2 infected cells was used to immunize 2-week-old SPF chickens, followed by challenging with the virulent IBDV, the survival rate was 30% at 14 days post primary immunization, however, the survival rate was 100% at 14 d after the booster vaccination. The ELISA antibody titers was up to 3.2 x 10(3) and neutralization antibody titer was 2536, significantly higher than those of one-shot vaccination, 8 x 10(2) and 1106, respectively. The immunized chickens did not show any clinical signs and histopathological changes of infection in 7-days trial time. The bursa/body-weight ratios were higher than those of the unimmunized control (P < 0.05). The virus-like-particle recombinant Vp2 protein expressed in insect cells promises to be a novel subunit vaccine and diagnostic reagent candidate for IBDV.
Animals
;
Baculoviridae
;
genetics
;
Cell Line
;
Chickens
;
Infectious bursal disease virus
;
immunology
;
Insecta
;
genetics
;
metabolism
;
Poultry Diseases
;
prevention & control
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
immunology
;
Viral Structural Proteins
;
biosynthesis
;
genetics
;
Viral Vaccines
;
immunology
9.Efficacy of VP2 protein expressed in E. coli for protection against highly virulent infectious bursal disease virus.
Abdul Rahman OMAR ; Chong Lee KIM ; Mohd Hair BEJO ; Aini IDERIS
Journal of Veterinary Science 2006;7(3):241-247
The ability of a heat-inactivated whole virus from a highly virulent infectious bursal disease virus (hvIBDV) and VP2 protein from hvIBDV expressed in E. coli provided protection against a hvIBDV challenge in specificpathogen- free (SPF) chickens. Six out of seven chickens that were injected three times with crude VP2 protein developed significant antibody titer against IBDV. However, only four out of the seven chickens survived the hvIBDV challenge. Despite showing low antibody titer profiles, all chickens immunized with the heat-inactivated whole virus also survived the challenged with hvIBDV. However, all of these chickens had bursal atrophy and mild to moderate depletion of lymphocytes. Thus, antibodies raised against IBDV VP2 protein expressed in E. coli and denatured IBDV proteins induced some degree of protection against mortality but not against bursal damage following challenge with hvIBDV.
Animals
;
Antibodies, Viral/blood
;
Birnaviridae Infections/immunology/prevention & control/*veterinary/virology
;
Chickens
;
Enzyme-Linked Immunosorbent Assay/veterinary
;
Escherichia coli/genetics
;
Immunization/standards/*veterinary
;
Infectious bursal disease virus/genetics/*immunology/pathogenicity
;
Poultry Diseases/*immunology/prevention&control/virology
;
Recombinant Proteins/genetics/*immunology
;
Specific Pathogen-Free Organisms
;
Vaccines, Attenuated/immunology/pharmacology
;
Vaccines, Synthetic/immunology/pharmacology
;
Viral Structural Proteins/biosynthesis/genetics/*immunology
;
Viral Vaccines/*immunology/pharmacology
10.Evaluation of modified vaccinia virus Ankara expressing VP2 protein of infectious bursal disease virus as an immunogen in chickens.
Flavia Adriana ZANETTI ; Maria Paula Del Medico ZAJAC ; Oscar Alberto TABOGA ; Gabriela CALAMANTE
Journal of Veterinary Science 2012;13(2):199-201
A recombinant modified vaccinia Ankara (MVA) virus expressing mature viral protein 2 (VP2) of the infectious bursal disease virus (IBDV) was constructed to develop MVA-based vaccines for poultry. We demonstrated that this recombinant virus was able to induce a specific immune response by observing the production of anti-IBDV-seroneutralizing antibodies in specific pathogen-free chickens. Besides, as the epitopes of VP2 responsible to induce IBDV-neutralizing antibodies are discontinuous, our results suggest that VP2 protein expressed from MVA-VP2 maintained the correct conformational structure. To our knowledge, this is the first report on the usefulness of MVA-based vectors for developing recombinant vaccines for poultry.
Animals
;
Antibodies, Viral
;
Birnaviridae Infections/prevention & control/*veterinary
;
Cells, Cultured
;
Chick Embryo
;
Chickens
;
Fibroblasts/metabolism
;
Infectious bursal disease virus/*immunology
;
Poultry Diseases/*prevention & control/virology
;
Specific Pathogen-Free Organisms
;
Vaccinia virus/*genetics/immunology/metabolism
;
Viral Structural Proteins/genetics/*immunology/metabolism
;
Viral Vaccines/*immunology